|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 for Regulation of p115RhoGEF and Leukemia-Associated RhoGEF
Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois
Heterotrimeric G proteins of the G12 family regulate the Rho GTPase through RhoGEFs that contain an amino-terminal regulator of G protein signaling (RGS) domain (RGS-RhoGEFs). Direct regulation of the activity of RGS-RhoGEFs p115 or leukemia-associated RhoGEF (LARG) by G
13 has previously been demonstrated. However, the precise biochemical mechanism by which G
13 stimulates the RhoGEF activity of these proteins has not yet been well understood. Based on the crystal structure of G
i1 in complex with RGS4, we mutated the G
13 residue lysine 204 to alanine (G
13K204A) and characterized the effect of this mutation in its regulation of RGS-RhoGEFs p115 or LARG. Compared with wild-type G
13, G
13K204A induced much less serum-response factor activation when expressed in HeLa cells. Recombinant G
13K204A exhibits normal function in terms of nucleotide binding, basal GTP hydrolysis, and formation of heterotrimer with 
. We found that lysine 204 of G
13 is important for interaction with the RGS domain of p115 or LARG and for the GTPase-activating protein activity of these proteins. In addition, the K204A mutation of G
13 impaired its regulation of the RhoGEF activity of p115 or LARG. We conclude that lysine 204 of G
13 is important for interaction with RGS-RhoGEFs and is critically involved in the regulation of their activity.
Received for publication May 3, 2004.
Accepted for publication July 13, 2004.
Address correspondence to: Dr. Tohru Kozasa, 835 South Wolcott Ave., M/C 868, Chicago, IL 60612. E-mail: tkozas{at}uic.edu
This article has been cited by other articles:
![]() |
N. Suzuki, K. Tsumoto, N. Hajicek, K. Daigo, R. Tokita, S. Minami, T. Kodama, T. Hamakubo, and T. Kozasa Activation of Leukemia-associated RhoGEF by G{alpha}13 with Significant Conformational Rearrangements in the Interface J. Biol. Chem., February 20, 2009; 284(8): 5000 - 5009. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Rojas, M. E. Yohe, S. Gershburg, T. Kawano, T. Kozasa, and J. Sondek G{alpha}q Directly Activates p63RhoGEF and Trio via a Conserved Extension of the Dbl Homology-associated Pleckstrin Homology Domain J. Biol. Chem., October 5, 2007; 282(40): 29201 - 29210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Huang, L. Dong, T. Kozasa, and G. C. Le Breton Signaling through G{alpha}13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion J. Biol. Chem., April 6, 2007; 282(14): 10210 - 10222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Meigs, J. Juneja, C. T. DeMarco, L. N. Stemmle, D. D. Kaplan, and P. J. Casey Selective Uncoupling of G{alpha}12 from Rho-mediated Signaling J. Biol. Chem., May 6, 2005; 280(18): 18049 - 18055. [Abstract] [Full Text] [PDF] |
||||